Since progesterone is essential for the maintenance and expansion of mammary gland stem cells (MaSCs), which could serve as a target for transformation and progression to breast carcinogenesis [12], we investigated whether the blockade of RANKL could result in the loss of mammary cells expressing stem cell markers. Here, TNFSF11 is linked to neoplasm.